PDGF and cardiovascular disease

Cytokine and Growth Factor Reviews

Volumn 15, Issue 4, 2004, Pages 237-254

  Raines, Elaine W ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Cardiovascular disease; PDGF; Regulation; Signaling; Smooth muscle cell

Indexed keywords

PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR A; PLATELET DERIVED GROWTH FACTOR AA; PLATELET DERIVED GROWTH FACTOR B; PLATELET DERIVED GROWTH FACTOR BB; PROTEIN TYROSINE KINASE INHIBITOR;

ARTERY CALCIFICATION; ARTERY INTIMA PROLIFERATION; ARTERY PERMEABILITY; ARTERY WALL; ATHEROGENESIS; BLOOD VESSEL TONE; BLOOD VESSEL WALL; CELL MIGRATION; CELLULAR DISTRIBUTION; CHIMERA; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY CONSTRICTION; GENE DISRUPTION; GENE OVEREXPRESSION; GENE TARGETING; HEART MUSCLE BIOPSY; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTIMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; RECEPTOR BLOCKING; RECEPTOR INTRINSIC ACTIVITY; REVIEW; SHEAR STRESS; VASCULAR SMOOTH MUSCLE;

EID: 2942635366     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2004.03.004     Document Type: Article

References (165)

1. Ross R. Atherosclerosis - an inflammatory disease. N. Engl. J. Med. 340(2):1999;115-126
2. Ross R., Glomset J., Kariya B., Harker L. A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc. Natl. Acad. Sci. U.S.A. 71(4):1974;1207-1210
3. Ross R., Glomset J., Kariya B., Raines E. Role of platelet factors in the growth of cells in culture. Natl. Cancer Inst. Monogr. 48:1978;103-108
4. Heldin C.H., Westermark B., Wasteson A. Platelet-derived growth factor. Isolation by a large-scale procedure and analysis of subunit composition. Biochem. J. 193(3):1981;907-913
5. Antoniades H.N. Human platelet-derived growth factor (PDGF): purification of PDGF-I and PDGF-II and separation of their reduced subunits. Proc. Natl. Acad. Sci. U.S.A. 78(12):1981;7314-7317
6. Raines E.W., Ross R. Platelet-derived growth factor. I. High yield purification and evidence for multiple forms. J. Biol. Chem. 257(9):1982;5154-5160
7. Seifert R.A., Hart C.E., Phillips P.E., Forstrom J.W., Ross R., Murray M.J., et al. Two different subunits associate to create isoform-specific platelet-derived growth factor receptors. J. Biol. Chem. 264(15):1989;8771-8778
8. Gilbertson D.G., Duff M.E., West J.W., Kelly J.D., Sheppard P.O., Hofstrand P.D., et al. Platelet-derived growth factor C (PDGF-C), a novel growth factor that binds to PDGF alpha and beta receptor. J. Biol. Chem. 276(29):2001;27406-27414
9. LaRochelle W.J., Jeffers M., McDonald W.F., Chillakuru R.A., Giese N.A., Lokker N.A., et al. PDGF-D, a new protease-activated growth factor. Nat. Cell Biol. 3(5):2001;517-521
10. Raines EW, Ross R, editors. Platelet-derived growth factor in vivo. Basel, Switzerland: Karger; 1993.
11. Heldin C.H., Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol. Rev. 79(4):1999;1283-1316
12. Barrett T.B., Benditt E.P. Platelet-derived growth factor gene expression in human atherosclerotic plaques and normal artery wall. Proc. Natl. Acad. Sci. U.S.A. 85(8):1988;2810-2814
13. Majesky M.W., Benditt E.P., Schwartz S.M. Expression and developmental control of platelet-derived growth factor A-chain and B-chain/Sis genes in rat aortic smooth muscle cells. Proc. Natl. Acad. Sci. U.S.A. 85(5):1988;1524-1528
14. Barrett T., Gajdusek C., Schwartz S., McDougall J., Benditt E. Expression of the sis gene by endothelial cells in culture and in vivo. Proc. Natl. Acad. Sci. U.S.A. 81:1984;6772-6774
15. Barrett T.B., Benditt E.P. Sis(platelet-derived growth factor B chain) gene transcript levels are elevated in human atherosclerotic lesions compared to normal artery. Proc. Natl. Acad. Sci. U.S.A. 84:1987;1099-1103
16. Evanko S.P., Raines E.W., Ross R., Gold L.I., Wight T.N. Proteoglycan distribution in lesions of atherosclerosis depends on lesion severity, structural characteristics, and the proximity of platelet-derived growth factor and transforming growth factor-beta. Am. J. Pathol. 152(2):1998;533-546
17. Uutela M., Lauren J., Bergsten E., Li X., Horelli-Kuitunen N., Eriksson U., et al. Chromosomal location, exon structure, and vascular expression patterns of the human PDGFC and PDGFC genes. Circulation. 103(18):2001;2242-2247
18. Changsirikulchai S., Hudkins K.L., Goodpaster T.A., Volpone J., Topouzis S., Gilbertson D.G., et al. Platelet-derived growth factor-D expression in developing and mature human kidneys. Kidney Int. 62(6):2002;2043-2054
19. Taneda S., Hudkins K.L., Topouzis S., Gilbertson D.G., Ophascharoensuk V., Truong L., et al. Obstructive uropathy in mice and humans: potential role for PDGF-D in the progression of tubulointerstitial injury. J. Am. Soc. Nephrol. 14(10):2003;2544-2555
20. Eitner F., Ostendorf T., Kretzler M., Cohen C.D., Eriksson U., Grone H.J., et al. PDGF-C expression in the developing and normal adult human kidney and in glomerular diseases. J. Am. Soc. Nephrol. 14(5):2003;1145-1153
21. Heldin C.H., Eriksson U., Ostman A. New members of the platelet-derived growth factor family of mitogens. Arch. Biochem. Biophys. 398(2):2002;284-290
22. Majesky M.W., Reidy M.A., Bowen-Pope D.F., Hart C.E., Wilcox J.N., Schwartz S.M. PDGF ligand and receptor gene expression during repair of arterial injury. J. Cell Biol. 111(5 (Pt 1)):1990;2149-2158
23. Rubin K., Tingstrom A., Hansson G.K., Larsson E., Ronnstrand L., Klareskog L., et al. Induction of B-type receptors for platelet-derived growth factor in vascular inflammation: possible implications for development of vascular proliferative lesions. Lancet. 1(8599):1988;1353-1356
24. Floege J., Hudkins K.L., Davis C.L., Schwartz S.M., Alpers C.E. Expression of PDGF alpha-receptor in renal arteriosclerosis and rejecting renal transplants. J. Am. Soc. Nephrol. 9(2):1998;211-223
25. Lindner V., Reidy M.A. Platelet-derived growth factor ligand and receptor expression by large vessel endothelium in vivo. Am. J. Pathol. 146(6):1995;1488-1497
26. Glagov S., Zarins C., Giddens D., Ku D. Hemodynamics and atherosclerosis. Insights and perspectives gained from studies of human arteries. Arch. Pathol. Lab. Med. 112:1988;1018-1031
27. Raines EW, Rosenfeld ME, Ross R. The role of macrophages. In: Fuster V, Ross R, Topol EJ, editors. Atherosclerosis and coronary artery disease. Philadelphia: Lippincott-Raven; 1996. p. 539-55.
28. -/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature. 394:1998;894-897
29. Gosling J., Slaymaker S., Gu L., Tseng S., Zlot C.H., Young S.G., et al. MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. J. Clin. Invest. 103(6):1999;773-778
30. Ni W., Egashira K., Kitamoto S., Kataoka C., Koyanagi M., Inoue S., et al. New anti-monocyte chemoattractant protein-1 gene therapy attenuates atherosclerosis in apolipoprotein E-knockout mice. Circulation. 103(16):2001;2096-2101
31. Ross R., Masuda J., Raines E.W., Gown A.M., Katsuda S., Sasahara M., et al. Localization of PDGF-B protein in macrophages in all phases of atherogenesis. Science. 248(4958):1990;1009-1012
32. Wilcox J.N., Smith K.M., Williams L.T., Schwartz S.M., Gordon D. Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization. J. Clin. Invest. 82(3):1988;1134-1143
33. Tanizawa S., Ueda M., van der Loos C.M., van der Wal A.C., Becker A.E. Expression of platelet derived growth factor B chain and beta receptor in human coronary arteries after percutaneous transluminal coronary angioplasty: an immunohistochemical study. Heart. 75(6):1996;549-556
34. Abe J., Deguchi J., Takuwa Y., Hara K., Ikari Y., Tamura T., et al. Tyrosine phosphorylation of platelet derived growth factor beta receptors in coronary artery lesions: implications for vascular remodelling after directional coronary atherectomy and unstable angina pectoris. Heart. 79(4):1998;400-406
35. Giese N.A., Marijianowski M.M., McCook O., Hancock A., Ramakrishnan V., Fretto L.J., et al. The role of alpha and beta platelet-derived growth factor receptor in the vascular response to injury in nonhuman primates. Arterioscler. Thromb. Vasc. Biol. 19(4):1999;900-909
36. Ueda M., Becker A.E., Kasayuki N., Kojima A., Morita Y., Tanaka S. In situ detection of platelet-derived growth factor-A and factor-B chain mRNA in human coronary arteries after percutaneous transluminal coronary angioplasty. Am. J. Pathol. 149(3):1996;831-843
37. Billingham M. Cardiac transplant atherosclerosis. Transpl. Proc. 19:1987;19-25
38. Demetris A., Zerbe T., Banner B. Morphology of solid organ allograft arteriopathy: identification of proliferating intimal cell populations. Transpl. Proc. 21:1989;3667-3669
39. Miller L.W. Allograft vascular disease: a disease not limited to hearts. J. Heart Lung Transpl. 11:1992;S32-S37
40. Libby P., Pober J.S. Chronic rejection. Immunity. 14:2001;387-397
41. Keck B., Bennett L., Rosendale J., Daily O., Novick R., Hosenpud J. Worldwide thoracic organ transplantation: a report from the UNOS/ISHLT International Registry for Thoracic Organ Transplantation. Clin. Transpl. 13:1999;35-49
42. Libby P., Zhao X.M. Allograft arteriosclerosis and immune-driven angiogenesis. Circulation. 107:2003;1237-1239
43. Fellstrom B., Dimeny E., Larsson E., Klareskog L., Tufveson G., Rubin K. Importance of PDGF receptor expression in accelerated atherosclerosis-chronic rejection. Transpl. Proc. 21(4):1989;3689-3691
44. Fellstrom B., Klareskog L., Larsson E., Tufveson G., Wahlberg J., Ronnstrand L., et al. Tissue distribution of macrophages, class II transplantation antigens, and receptors for platelet-derived growth factor in normal and rejected human kidneys. Transpl. Proc. 19:1987;3625-3627
45. Zhao X.M., Frist W.H., Yeoh T.K., Miller G.G. Confirmation of alternatively spliced platelet-derived growth factor-A chain and correlation with expression of PDGF receptor-alpha in human cardiac allografts. Transplantation. 59(4):1995;605-611
46. Bonthron D.T., Morton C.C., Orkin S.H., Collins T. Platelet-derived growth factor A chain: gene structure, chromosomal location, and basis for alternative mRNA splicing. Proc. Natl. Acad. Sci. U.S.A. 85(5):1988;1492-1496
47. Rorsman F., Bywater M., Knott T., Scott J., Betsholtz C. Structural characterization of the human platelet-derived growth factor A-chain cDNA and gene: alternative exon usage predicts two different precursor proteins. Mol. Cell Biol. 8:1988;571-577
48. Matoskova B., Rorsman F., Svensson V., Betsholtz C. Alternative splicing of the platelet-derived growth factor A-chain transcript occurs in normal as well as tumor cells and is conserved among mammalian species. Mol. Cell Biol. 9:1989;3148-3150
49. Raines E.W., Ross R. Compartmentalization of PDGF on extracellular binding sites dependent on exon-6-encoded sequences. J. Cell Biol. 116(2):1992;533-543
50. Shaddy R.E., Hammond E.H., Yowell R.L. Immunohistochemical analysis of platelet-derived growth factor and basic fibroblast growth factor in cardiac biopsy and autopsy specimens of heart transplant patients. Am. J. Cardiol. 77(14):1996;1210-1215
51. Langille B. Remodeling of developing and mature arteries: endothelium, smooth muscle, and matrix. J. Cardiovasc. Pharmacol. 21:1993;S11-S17
52. Owens G.K., Schwartz S.M. Alterations in vascular smooth muscle mass in the spontaneously hypertensive rat. Role of cellular hypertrophy, hyperploidy, and hyperplasia. Circ. Res. 51:1982;280-289
53. Negoro N., Kanayama Y., Haraguchi M., Umetani N., Nishimura M., Konishi Y., et al. Blood pressure regulates platelet-derived growth factor A-chain gene expression in vascular smooth muscle cells in vivo. An autocrine mechanism promoting hypertensive vascular hypertrophy. J. Clin. Invest. 95(3):1995;1140-1150
54. Fukuda N., Kishioka H., Satoh C., Nakayama T., Watanabe Y., Soma M., et al. Role of long-form PDGF A-chain in the growth of vascular smooth muscle cells from spontaneously hypertensive rats. Am. J. Hypertens. 10:1997;1117-1124
55. Kim S., Zhan Y., Izumi Y., Yasumoto H., Yano M., Iwao H. In vivo activation of rat aortic platelet-derived growth factor and epidermal growth factor receptors by angiotensin II and hypertension. Arterioscler. Thromb. Vasc. Biol. 20:2000;2539-2545
56. Kitami Y., Inui H., Uno S., Inagami T. Molecular structure and transcriptional regulation of the gene for the platelet-derived growth factor alpha receptor in cultured vascular smooth muscle cells. J. Clin. Invest. 96:1995;558-567
57. Kitami Y., Fukuoka T., Hiwada K., Inagami T. A high level of CCAAT-enhancer binding protein-delta expression is a major determinant for markedly elevated differential gene expression of the platelet-derived growth factor-alpha receptor in vascular smooth muscle cells of genetically hypertensive rats. Circ. Res. 84:1999;64-73
58. Fukuda N., Kubo A., Watanabe Y., Nakayama T., Soma M., Izumi Y., et al. Antisense oligodeoxynucleotide complementary to platelet-derived growth factor A-chain messenger RNA inhibits the arterial proliferation in spontaneously hypertensive rats without altering their blood pressures. J. Hypertens. 15(10):1997;1123-1136
59. Folkow B. Physiological aspects of primary hypertension. Phsiol. Rev. 62:1982;347-504
60. Majesky M.W., Daemen M.J., Schwartz S.M. Alpha 1-adrenergic stimulation of platelet-derived growth factor A-chain gene expression in rat aorta. J. Biol. Chem. 265(2):1990;1082-1088
61. Hajra L., Evans A., Chen M., Hyduk S., Collins T., Cybulsky M. The NF-kappa B signal transduction pathway in aortic endothelial cells is primed for activation in regions predisposed to atherosclerotic lesion formation. Proc. Natl. Acad. Sci. U.S.A. 97:2000;9052-9057
62. Mondy J.S., Lindner V., Miyashiro J.K., Berk B.C., Dean R.H., Geary R.L. Platelet-derived growth factor ligand and receptor expression in response to altered blood flow in vivo. Circ. Res. 81(3):1997;320-327
63. Zerwes H.G., Risau W. Polarized secretion of a platelet-derived growth factor-like chemotactic factor by endothelial cells in vitro. J. Cell Biol. 105(5):1987;2037-2041
64. Kraiss L., Kirkman T., Kohler T., Zierler B., Clowes A. Shear stress regulates smooth muscle proliferation and neointimal thickening in porous polytetrafluoroethylene grafts. Arterioscler. Thromb. 11:1991;1844-1852
65. Clowes A., Kirkman T., Reidy M. Mechanisms of arterial graft healing. Rapid transmural capillary ingrowth provides a source of intimal endothelium and smooth muscle in porous PTFE prostheses. Am. J. Pathol. 123:1986;220-230
66. Kraiss L., Raines E., Wilcox J., Seifert R., Barrett T., Kirkman T., et al. Regional expression of the platelet-derived growth factor and its receptors in a primate graft model of vessel wall assembly. J. Clin. Invest. 92:1993;338-348
67. Kraiss L., Geary R., Mattsson E., Vergel S., Au Y., Clowes A. Acute reductions in blood flow and shear stress induce platelet-derived growth factor-A expression in baboon prosthetic grafts. Circ. Res. 79:1996;45-53
68. Billett M., Adbeish I., Alrokayan S., Bennett A., Marenah C., White D. Increased expression of genes for platelet-derived growth factor in circulating mononuclear cells of hypercholesterolemic patients. Arterioscler. Thromb. 16:1996;399-406
69. Smithies O., Maeda N. Gene targeting approaches to complex genetic diseases:Atherosclerosis and essential hypertension. Proc. Natl. Acad. Sci. U.S.A. 92:1995;5266-5272
70. Leveen P., Pekny M., Gebre-Medhin S., Swolin B., Larsson E., Betsholtz C. Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. Genes. Dev. 8(16):1994;1875-1887
71. Bostrom H., Willetts K., Pekny M., Leveen P., Lindahl P., Hedstrand H., et al. PDGF-A signaling is a critical event in lung alveolar myofibroblast development and alveogenesis. Cell. 85(6):1996;863-873
72. Soriano P. Abnormal kidney development and hematological disorders in PDGF beta-receptor mutant mice. Genes Dev. 8(16):1994;1888-1896
73. Soriano P. The PDGF alpha receptor is required for neural crest cell development and for normal patterning of the somites. Development. 124(14):1997;2691-2700
74. Clowes A.W., Reidy M.A., Clowes M.M. Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. Lab. Invest. 49(3):1983;327-333
75. Fingerle J., Au Y.P., Clowes A.W., Reidy M.A. Intimal lesion formation in rat carotid arteries after endothelial denudation in absence of medial injury. Arteriosclerosis. 10(6):1990;1082-1087
76. Han D.K., Haudenschild C.C., Hong M.K., Tinkle B.T., Leon M.B., Liau G. Evidence for apoptosis in human atherogenesis and in a rat vascular injury model. Am. J. Pathol. 147(2):1995;267-277
77. Jackson C.L., Raines E.W., Ross R., Reidy M.A. Role of endogenous platelet-derived growth factor in arterial smooth muscle cell migration after balloon catheter injury. Arterioscler. Thromb. 13(8):1993;1218-1226
78. Clowes A.W., Schwartz S.M. Significance of quiescent smooth muscle migration in the injured rat carotid artery. Circ. Res. 56(1):1985;139-145
79. Panek R.L., Dahring T.K., Olszewski B.J., Keiser J.A. PDGF receptor protein tyrosine kinase expression in the balloon-injured rat carotid artery. Arterioscler. Thromb. Vasc. Biol. 17(7):1997;1283-1288
80. Lewis C., Olson N., Raines E., Reidy M., Jackson C. Modulation of smooth muscle proliferation in rat carotid artery by platelet-derived mediators and fibroblast growth factor-2. Platelets. 12:2001;352-358
81. Ferns G.A., Raines E.W., Sprugel K.H., Motani A.S., Reidy M.A., Ross R. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science. 253(5024):1991;1129-1132
82. Leppanen O., Janjic N., Carlsson M.A., Pietras K., Levin M., Vargeese C., et al. Intimal hyperplasia recurs after removal of PDGF-AB and PDGF-BB inhibition in the rat carotid artery injury model. Arterioscler. Thromb. Vasc. Biol. 20(11):2000;E89-E95
83. Noiseux N., Boucher C.H., Cartier R., Sirois M.G. Bolus endovascular PDGFR-beta antisense treatment suppressed intimal hyperplasia in a rat carotid injury model. Circulation. 102(11):2000;1330-1336
84. Sirois M.G., Simons M., Edelman E.R. Antisense oligonucleotide inhibition of PDGFR-beta receptor subunit expression directs suppression of intimal thickening. Circulation. 95(3):1997;669-676
85. Myllarniemi M., Calderon L., Lemstrom K., Buchdunger E., Hayry P. Inhibition of platelet-derived growth factor receptor tyrosine kinase inhibits vascular smooth muscle cell migration and proliferation. FASEB J. 11(13):1997;1119-1126
86. Yamasaki Y., Miyoshi K., Oda N., Watanabe M., Miyake H., Chan J., et al. Weekly dosing with the platelet-derived growth factor receptor tyrosine kinase inhibitor SU9518 significantly inhibits arterial stenosis. Circ. Res. 88(6):2001;630-636
87. Yu J.C., Lokker N.A., Hollenbach S., Apatira M., Li J., Betz A., et al. Efficacy of the novel selective platelet-derived growth factor receptor antagonist CT52923 on cellular proliferation, migration, and suppression of neointima following vascular injury. J. Pharmacol. Exp. Ther. 298(3):2001;1172-1178
88. Hart C.E., Kraiss L.W., Vergel S., Gilbertson D., Kenagy R., Kirkman T., et al. PDGFbeta receptor blockade inhibits intimal hyperplasia in the baboon. Circulation. 99(4):1999;564-569
89. Jawien A., Bowen-Pope D.F., Lindner V., Schwartz S.M., Clowes A.W. Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. J. Clin. Invest. 89(2):1992;507-511
90. Bendeck M.P., Regenass S., Tom W.D., Giachelli C.M., Schwartz S.M., Hart C., et al. Differential expression of alpha 1 type VIII collagen in injured platelet-derived growth factor-BB - stimulated rat carotid arteries. Circ. Res. 79(3):1996;524-531
91. Nabel E.G., Yang Z., Liptay S., San H., Gordon D., Haudenschild C.C., et al. Recombinant platelet-derived growth factor B gene expression in porcine arteries induce intimal hyperplasia in vivo. J. Clin. Invest. 91(4):1993;1822-1829
92. Crosby J.R., Seifert R.A., Soriano P., Bowen-Pope D.F. Chimaeric analysis reveals role of Pdgf receptors in all muscle lineages. Nat. Genet. 18(4):1998;385-388
93. Crosby J.R., Tappan K.A., Seifert R.A., Bowen-Pope D.F. Chimera analysis reveals that fibroblasts and endothelial cells require platelet-derived growth factor receptorbeta expression for participation in reactive connective tissue formation in adults but not during development. Am. J. Pathol. 154(5):1999;1315-1321
94. Kumar A., Lindner V. Remodeling with neointima formation in the mouse carotid artery after cessation of blood flow. Arterioscler. Thromb. Vasc. Biol. 17:1997;2238-2244
95. Buetow B., Tappan K., Crosby J., Seifert R., Bowen-Pope D. Chimera analysis supports a predominant role of PDGFRbeta in promoting smooth-muscle cell chemotaxis after arterial injury. Am. J. Pathol. 163:2003;979-984
96. Nakashima Y., Plump A.S., Raines E.W., Breslow J.L., Ross R. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler. Thromb. 14(1):1994;133-140
97. Breslow J.L. Mouse models of atherosclerosis. Science. 272:1996;685-688
98. Rutherford C., Martin W., Carrier M., Anggard E.E., Ferns G.A. Endogenously elicited antibodies to platelet derived growth factor-BB and platelet cytosolic protein inhibit aortic lesion development in the cholesterol-fed rabbit. Int. J. Exp. Pathol. 78(1):1997;21-32
99. Lamb D.J., Avades T.Y., Ferns G.A. Endogenous neutralizing antibodies against platelet-derived growth factor-aa inhibit atherogenesis in the cholesterol-fed rabbit. Arterioscler. Thromb. Vasc. Biol. 21(6):2001;997-1003
100. Brown M.S., Goldstein J.L. Analysis of a mutant strain of human fibroblasts with a defect in the internalization of receptor-bound low density lipoprotein. Cell. 9:1976;663-674
101. Sano H., Sudo T., Yokode M., Murayama T., Kataoka H., Takakura N., et al. Functional blockade of platelet-derived growth factor receptor-beta but not of receptor-alpha prevents vascular smooth muscle cell accumulation in fibrous cap lesions in apolipoprotein E-deficient mice. Circulation. 103(24):2001;2955-2960
102. Kozaki K., Kaminski W.E., Tang J., Hollenbach S., Lindahl P., Sullivan C., et al. Blockade of platelet-derived growth factor or its receptors transiently delays but does not prevent fibrous cap formation in ApoE null mice. Am. J. Pathol. 161(4):2002;1395-1407
103. Swertfeger D., Bu G., Hui D. Low density lipoprotein receptor-related protein mediates apolipoprotein E inhibition of smooth muscle cell migration. J. Biol. Chem. 277:2002;4141-4146
104. Herz J., Strickland D.K. LRP: a multifunctional scavenger and signaling receptor. J. Clin. Invest. 108:2001;779-784
105. Luoma J., Hiltunen T., Sarkioja T., Moestrup S., Gliemann J., Kodama T., et al. Expression of alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein and scavenger receptor in human atherosclerotic lesions. J. Clin. Invest. 93:1994;2014-2021
106. Boucher P., Liu P., Gotthardt M., Hiesberger T., Anderson R., Herz J. Platelet-derived growth factor mediates tyrosine phosphorylation of the cytoplasmic domain of the low density lipoprotein receptor-related protein in caveolae. J. Biol. Chem. 277:2002;15507-15513
107. Loukinova E., Ranganathan S., Kuznetsov S., Gorlatova N., Migliorini M., Loukinov D., et al. Platelet-derived growth factor (PDGF)-induced tyrosine phosphorylation of the low density lipoprotein receptor-related protein (LRP). Evidence for integrated co-receptor function between LRP and the PDGF. J. Biol. Chem. 277:2002;15499-15506
108. Lupu F., Heim D., Bachmann F., Kruithof E.K. Expression of LDL receptor-related protein/alpha 2-macroglobulin receptor in human normal and atherosclerotic arteries. Arterioscler. Thromb. 14(9):1994;1438-1444
109. Boucher P., Gotthardt M., Li W., Anderson R., Herz J. LRP: role in vascular wall integrity and protection from atherosclerosis. Science. 300:2003;329-332
110. Buchdunger E., Zimmermann J., Mett H., Meyer T., Muller M., Regenass U., et al. Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminopyrimidine class. Proc. Natl. Acad. Sci. U.S.A. 92:1995;2258-2562
111. Bilder G., Wentz T., Leadley R., Amin D., Byan L., O'Conner B., et al. Restenosis following angioplasty in the swine coronary artery is inhibited by an orally active PDGF-receptor tyrosine kinase inhibitor, RPR101511A. Circulation. 99(25):1999;3292-3299
112. Hachida M., Zhang X., Lu H., Hoshi H., Furutani Y., Matsuoka R., et al. Association between the degree of platelet-derived growth factor-A chain mRNA expression and coronary arteriosclerosis in the transplanted heart. Heart Vessels. 13(1):1998;24-29
113. Higgy N.A., Davidoff A.W., Grothman G.T., Hollenberg M.D., Benediktsson H., Paul L.C. Expression of platelet-derived growth factor receptor in rat heart allografts. J. Heart Lung Transpl. 10(6):1991;1012-1022
114. Lemstrom K., Sihvola R., Koskinen P. Expression of platelet-derived growth factor in the development of cardiac allograft vasculopathy in the rat. Transpl. Proc. 29(1-2):1997;1045-1046
115. Mancini M.C., Evans J.T. Role of platelet-derived growth factor in allograft vasculopathy. Ann. Surg. 231(5):2000;682-688
116. Sihvola R., Koskinen P., Myllarniemi M., Loubtchenkov M., Hayry P., Buchdunger E., et al. Prevention of cardiac allograft arteriosclerosis by protein tyrosine kinase inhibitor selective for platelet-derived growth factor receptor. Circulation. 99(17):1999;2295-2301
117. Sihvola R.K., Tikkanen J.M., Krebs R., Aaltola E.M., Buchdunger E., Laitinen O., et al. Platelet-derived growth factor receptor inhibition reduces allograft arteriosclerosis of heart and aorta in cholesterol-fed rabbits. Transplantation. 75(3):2003;334-339
118. Lemstrom K., Sihvola R., Tikkanen J., Aaltola E., Buchdunger E., Laitinen O., et al. PDGF receptor inhibition prevents cardiac allograft arteriosclerosis in cholesterol-fed rabbits. Transpl. Proc. 33(1-2):2001;318
119. Alonso D., Starek P., Minick C. Studies on the pathogenesis of atheroarteriosclerosis induced in rabbit cardiac allografts by the synergy of graft rejection and hypercholesterolemia. Am. J. Pathol. 87:1977;415-442
120. Aird W., Edelberg J., Weiler-Guettle H., Simmons W., Smith T., Rosenberg R. Vascular bed-specific expression of an endothelial cell gene is programmed by the tissue microenvironment. J. Cell Biol. 138:1997;1117-1124
121. Edelberg J.M., Aird W.C., Wu W., Rayburn H., Mamuya W.S., Mercola M., et al. PDGF mediates cardiac microvascular communication. J. Clin. Invest. 102(4):1998;837-843
122. Edelberg J.M., Lee S.H., Kaur M., Tang L., Feirt N.M., McCabe S., et al. Platelet-derived growth factor-AB limits the extent of myocardial infarction in a rat model: feasibility of restoring impaired angiogenic capacity in the aging heart. Circulation. 105(5):2002;608-613
123. Edelberg J.M., Tang L., Hattori K., Lyden D., Rafii S. Young adult bone marrow-derived endothelial precursor cells restore aging-impaired cardiac angiogenic function. Circ. Res. 90(10):2002;E89-E93
124. Li X., Ponten A., Aase K., Karlsson L., Abramsson A., Uutela M., et al. PDGF-C is a new protease-activated ligand for the PDGF alpha-receptor. Nat. Cell Biol. 2(5):2000;302-309
125. Bergsten E., Uutela M., Li X., Pietras K., Ostman A., Heldin C., et al. PDGF-D is a specific, protease-activated ligand for the PDGF beta-receptor. Nat. Cell Biol. 3:2001;512-516
126. Schonberger J., Seidman C. Many roads lead to a broken heart: the genetics of dilated cardiomyopathy. Am. J. Hum. Genet. 69:2001;249-260
127. Ponten A., Li X., Thoren P., Aase K., Sjoblom T., Ostman A., et al. Transgenic overexpression of platelet-derived growth factor-C in the mouse heart induces cardiac fibrosis, hypertrophy, and dilated cardiomyopathy. Am. J. Pathol. 163(2):2003;673-682
128. Hart C.E., Bailey M., Curtis D.A., Osborn S., Raines E., Ross R., et al. Purification of PDGF-AB and PDGF-BB from human platelet extracts and identification of all three PDGF dimers in human platelets. Biochemistry. 29(1):1990;166-172
129. Fang L, Yan Y, Komuves LG, Yonkovich S, Sullivan CM, Stringer B, et al. PDGF C is a selective {alpha} platelet-derived growth factor receptor agonist that is highly expressed in platelet {alpha} granules and vascular smooth muscle. Arterioscler Thromb Vasc Biol 2004.
130. Berk B.C., Alexander R.W., Brock T.A., Gimbrone M.A. Jr., Webb R.C. Vasoconstriction: a new activity for platelet-derived growth factor. Science. 232(4746):1986;87-90
131. Sachinidis A., Locher R., Hoppe J., Vetter W. The platelet-derived growth factor isomers, PDGF-AA, PDGF-AB and PDGF-BB, induce contraction of vascular smooth muscle cells by different intracellular mechanisms. FEBS Lett. 275:1990;95-98
132. 2+ in rabbit isolated ear artery by platelet-derived growth factor. Br. J. Pharmacol. 114:1995;138-142
133. Cunningham L., Brecher P., Cohen R. Platelet-derived growth factor receptors on macrovascular endothelial cells mediate relaxation via nitric oxide in rat aorta. J. Clin. Invest. 89:1992;878-882
134. Yamawaki H., Sato K., Hori M., Ozaki H., Karaki H. Platelet-derived growth factor causes endothelium-independent relaxation of rabbit mesenteric artery via the release of a prostanoid. Br. J. Pharmacol. 131:2000;1546-1552
135. Ikeda M., Morita C., Mizuno M., Sada T., Koike H., Kurokawa K. PDGF-BB decreases systolic blood pressure through an increase in macrovascular compliance in rats. Am. J. Physiol. 273(4 (Pt 2)):1997;H1719-H1726
136. Bowen-Pope D.F., Malpass T.W., Foster D.M., Ross R. Platelet-derived growth factor in vivo: levels, activity, and rate of clearance. Blood. 64(2):1984;458-469
137. Bryckaert M., Rendu F., Tobelem G., Wasteson A. Collagen-induced binding to human platelets of platelet-derived growth factor leading to inhibition of P43 and P20 phosphorylation. J. Biol. Chem. 264:1989;4336-4341
138. Vassbotn F.S., Heldin C.H., Holmsen H. Negative feedback regulation of human platelets via autocrine activation of the platelet-derived growth factor alpha-receptor. J. Biol. Chem. 269:1994;13874-13879
139. Hansson G., Libby P., Schonbeck U., Yan Z. Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ. Res. 91:2002;281-291
140. Inaba T., Shimano H., Gotoda T., Harada K., Shimada M., Ohsuga J., et al. Expression of platelet-derived growth factor beta receptor on human monocyte-derived macrophages and effects of platelet-derived growth factor BB dimer on the cellular function. J. Biol. Chem. 268:1993;24353-24360
141. Inaba T., Kawamura M., Gotoda T., Harada K., Shimada M., Ohsuga J., et al. Effects of platelet-derived growth factor on the synthesis of lipoprotein lipase in human monocyte-derived macrophages. Arterioscler. Thromb. Vasc. Biol. 15:1995;522-528
142. Stein Y., Stein O. Lipoprotein lipase and atherosclerosis. Atherosclerosis. 170:2003;1-9
143. Deuel T.F., Senior R.M., Huang J.S., Griffin G.L. Chemotaxis of monocytes and neutrophils to platelet-derived growth factor. J. Clin. Invest. 69(4):1982;1046-1049
144. Shure D., Senior R.M., Griffin G.L., Deuel T.F. PDGF AA homodimers are potent chemoattractants for fibroblasts and neutrophils, and for monocytes activated by lymphocytes or cytokines. Biochem. Biophys. Res. Commun. 186(3):1992;1510-1514
145. Tzeng D., Deuel T., Huang J., Baehner R. Platelet-derived growth factor promotes human peripheral monocyte activation. Blood. 66:1985;179-183
146. Ernofsson M., Siegbahn A. Platelet-derived growth factor-BB and monocyte chemotactic protein-1 induce human peripheral blood monocytes to express tissue factor. Thromb. Res. 83(4):1996;307-320
147. Gersuk G.M., Westermark B., Mohabeer A.J., Challita P.M., Pattamakom S., Pattengale P.K. Inhibition of human natural killer cell activity by platelet-derived growth factor (PDGF). III. Membrane binding studies and differential biological effect of recombinant PDGF isoforms. Scand. J. Immunol. 33(5):1991;521-532
148. Daynes R.A., Dowell T., Araneo B.A. Platelet-derived growth factor is a potent biologic response modifier of T cells. J. Exp. Med. 174(6):1991;1323-1333
149. Araneo B. Natural regulators of T-cell lymphokine production in vivo. J. Immunother. 12:1992;174-179
150. Wiedmeier S., Mu H., Araneo B., Daynes R. Age- and microenvironment- associated influences by platelet-derived growth factor on T cell function. J. Immunol. 152:1994;3417-3426
151. Knighton D., Silver I., Hunt T. Regulation of wound-healing angiogenesis-effect of oxygen gradients and inspired oxygen concentration. Surgery. 90:1981;262-270
152. Cao R., Brakenhielm E., Li X., Pietras K., Widenfalk J., Ostman A., et al. Angiogenesis stimulated by PDGF-CC, a novel member in the PDGF family, involves activation of PDGFR-alphaalpha and PDGFR-alphabeta receptors. FASEB J. 16(12):2002;1575-1583
153. Li H., Fredriksson L., Li X., Eriksson U. PDGF-D is a potent transforming and angiogenic growth factor. Oncogene. 22(10):2003;1501-1510
154. Brown D.M., Hong S.P., Farrell C.L., Pierce G.F., Khouri R.K. Platelet-derived growth factor BB induces functional vascular anastomoses in vivo. Proc. Natl. Acad. Sci. U.S.A. 92(13):1995;5920-5924
155. Abramsson A., Lindblom P., Betsholtz C. Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors. J. Clin. Invest. 112:2003;1142-1151
156. Enge M., Bjarnegard M., Gerhardt H., Gustafsson E., Kalen M., Asker N., et al. Endothelium-specific platelet-derived growth factor-B ablation mimics diabetic retinopathy. EMBO J. 21:2002;4307-4316
157. Gerhardt H., Betsholtz C. Endothelial-pericyte interactions in angiogenesis. Cell Tissue Res. 314:2003;15-23
158. Lindblom P., Gerhardt H., Liebner S., Abramsson A., Enge M., Hellstrom M., et al. Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall. Genes Dev. 17:2003;1835-1840
159. Betsholtz C., Karlsson L., Lindah P. Developmental roles of platelet-derived growth factors. Bioessays. 23:2001;494-507
160. Buetow B., Crosby J., Kaminski W., Ramachandran R., Lindahl P., Martin P., et al. Platelet-derived growth factor B-chain of hematopoietic origin is not necessary for granulation tissue formation and its absence enhances vascularization. Am. J. Pathol. 159:2001;1869-1876
161. Klinghoffer R., Mueting-Nelsen P., Faerman A., Shani M., Soriano P. The two PDGF receptors maintain conserved signaling in vivo despite divergent embryological functions. Mol. Cell. 7:2002;343-354
162. Li S., Eriksson U. Novel PDGF family members:PDGF-C and PDGF-D. Cytokine Growth Factor Rev. 14:2003;91-98
163. Grako K., Stallcup W. Participation of the NG2 proteoglycan in rat aortic smooth muscle cell responses to platelet-derived growth factor. Exp. Cell Res. 221:1995;231-240
164. Grako K., Ochiya T., Barritt D., Nishiyama A., Stallcup W. PDGF (alpha)-receptor is unresponsive to PDGF-AA in aortic smooth muscle cells from the NG2 knockout mouse. J. Cell Sci. 112:1999;905-915
165. Hu Y., Bock G., Wick G., Xu Q. Activation of PDGF receptor alpha in vascular smooth muscle cells by mechanical stress. FASEB J. 12:1998;1135-1142